<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Drug Development Consultant &#38; Regulatory Consultant &#187; Friability</title>
	<atom:link href="http://www.damienbove.com/tag/friability/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.damienbove.com</link>
	<description>Damien Bove Shares The Expertise</description>
	<lastBuildDate>Thu, 09 Feb 2012 16:32:39 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Drug Regulators Publish Q4B Annex9 &amp; 10</title>
		<link>http://www.damienbove.com/2009/09/30/drug-regulators-publish-q4b-annex9-tablet-friability-general-chapter/</link>
		<comments>http://www.damienbove.com/2009/09/30/drug-regulators-publish-q4b-annex9-tablet-friability-general-chapter/#comments</comments>
		<pubDate>Wed, 30 Sep 2009 09:19:23 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Friability]]></category>
		<category><![CDATA[Q4B]]></category>

		<guid isPermaLink="false">http://www.damienbove.com/?p=798</guid>
		<description><![CDATA[This annex is the result of the Q4B process for the Tablet Friability General Chapter. The proposed texts were submitted by the Pharmacopoeial Discussion Group (PDG). <a href="http://www.damienbove.com/2009/09/30/drug-regulators-publish-q4b-annex9-tablet-friability-general-chapter/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
			<content:encoded><![CDATA[<h1>FDA Publishes Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions &#8211; Annex 9: Tablet Friability General Chapter</h1>
<p>This annex is the result of the Q4B process for the Tablet Friability General Chapter. The proposed texts were submitted by the Pharmacopoeial Discussion Group (PDG).<br />
Full Text <a title="FDA guidance" href="http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM176888.pdf" target="_blank">Here</a></p>
<h1>FDA Publishes Q4B Evaluation and Recommendation of Pharmacopeial Texts for Use in ICH Regions &#8211; Annex 10: Polycrylamide Gel Electrophoresis General Chapter</h1>
<p>This annex is the result of the Q4B process for the Polyacrylamide Gel Electrophoresis General Chapter.  The proposed texts were submitted by the Pharmacopoeial Discussion Group (PDG).</p>
<p>The ICH Steering Committee, based on the evaluation by the Q4B Expert Working Group  (EWG), recommends that the official pharmacopoeial texts, the section in Ph.Eur. 2.2.31.  Electrophoresis entitled “Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS PAGE)”, JP General Information 23. SDS-Polyacrylamide Gel Electrophoresis, and USP &lt;1056&gt; Biotechnology-derived Articles – Polyacrylamide Gel Electrophoresis, can be used as 120 interchangeable in the ICH regions.</p>
<p>Full Text <a title="FDA guidance" href="http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM176889.pdf " target="_blank">Here</a></p>
<p class="MsoNormal">If you would like more detail in this area please get in touch with Damien Bové damien.bove@idaconsultants.com</p>
<p>Damien Bové works as a drug development consultant (pharmaceutical or biotechnology) and regulatory consultant, we work with our clients to define a drug  development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.</p>
<p style="text-align: center;"><a title="How To Write a Business Plan" href="http://www.damienbove.com/how-to-write-a-business-plan/"><img class="size-full wp-image-640 aligncenter" title="How To Write A Business Plan" src="http://www.damienbove.com/wordpress/wp-content/uploads/2009/07/ida_100programme_515x64_LowRes.jpg" alt="ida 100programme 515x64 LowRes Drug Regulators Publish Q4B Annex9 & 10" width="489" height="61" /></a></p>
<h1 style="text-align: left;">Turn your Business Into an Investor Magnet</h1>
<h2 style="text-align: left;">How to Write a Business Plan &#8211; Free E-Course</h2>
<p>Get the secrets that turns your project into an investment magnet, <strong>100% of our clients raise the finance they need to take their projects to the next stage</strong>, we will share these secrets with you. &#8211; <a title="How To Write a Business Plan" href="http://www.damienbove.com/how-to-write-a-business-plan/" target="_self">Sign up for Free</a></p>
<h1><strong>Grow your Expertise for Free</strong></h1>
<p><span style="font-weight: normal; font-size: 13px; ">As you know this website is a great resource for keeping up to date with developments and regulations, why not get our </span><span style="font-size: 13px; "><strong>FREE</strong></span><span style="font-weight: normal; font-size: 13px; "><strong> monthly regulatory and market round up</strong></span><span style="font-weight: normal; font-size: 13px; ">. You can un-subscribe at any time and we do not share your details with anybody.</span></p>
<form action="http://www.damienbove.com/cgi-bin/arp3/arp3-formcapture.pl" method="POST">
<div>
<p>First name</p>
<input name="first_name" size="20" type="text" /></div>
<div>
<p>E-mail address</p>
<input name="email" size="20" type="text" /></div>
<input name="subscription_type" type="hidden" value="E" />
<div>
<input type="submit" value="Go »" /></div>
<input name="id" type="hidden" value="2" />
<input name="extra_ar" type="hidden" /> </form>
<div id="_mcePaste" style="overflow: hidden; position: absolute; left: -10000px; top: 0px; width: 1px; height: 1px;">This guideline ap</div>
<div id="_mcePaste" style="overflow: hidden; position: absolute; left: -10000px; top: 0px; width: 1px; height: 1px;">recombinant vaccines for the prevention and treatment of infectious disease, and provides guidance on quality, non-clinical and clinical aspects.</div>
<dl id="attachment_191" class="wp-caption aligncenter" style="display: block; margin-left: auto; margin-right: auto; text-align: center; background-color: #f3f3f3; padding-top: 4px; margin-top: 10px; margin-bottom: 10px; -webkit-border-top-right-radius: 3px 3px; -webkit-border-top-left-radius: 3px 3px; -webkit-border-bottom-left-radius: 3px 3px; -webkit-border-bottom-right-radius: 3px 3px; border: 1px solid #dddddd;">
<dt class="wp-caption-dt"><a href="http://www.damienbove.com/?page_id=183"><img class="size-full wp-image-191" style="padding: 0px; margin: 0px; border: 0px none initial;" title="Free Strategy Consultation - Biotech Pharma Regualtory" src="http://www.damienbove.com/wordpress/wp-content/uploads/2009/04/ida_consultants_freestrategyconsultation_515x64.jpg" alt="ida consultants freestrategyconsultation 515x64 Drug Regulators Publish Q4B Annex9 & 10" width="515" height="64" /></a></dt>
</dl>
]]></content:encoded>
			<wfw:commentRss>http://www.damienbove.com/2009/09/30/drug-regulators-publish-q4b-annex9-tablet-friability-general-chapter/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

